Cleveland Clinic and IBM recently convened a joint forum highlighting rapid advances in artificial intelligence and quantum computing and their growing role in transforming healthcare research. The event underscored how the long-standing collaboration between the two organizations is moving beyond theoretical innovation into real-world biomedical applications, including drug discovery, disease modeling, and clinical data analysis.

At the center of the discussion was the continued development of the Discovery Accelerator partnership, a 10-year initiative that combines Cleveland Clinic’s clinical and research expertise with IBM’s advanced computing capabilities, including high-performance computing, AI, and quantum systems. The collaboration has already led to milestones such as the deployment of IBM’s Quantum System One on Cleveland Clinic’s campus and early breakthroughs in computational biology.

Speakers emphasized how hybrid approaches—blending quantum computing with classical supercomputing and AI—are beginning to unlock complex biological problems that were previously beyond reach. Recent research efforts have included large-scale molecular simulations and work aimed at improving predictive models for conditions such as cancer and neurological disease.

The forum also highlighted the importance of building a collaborative ecosystem, bringing together researchers, clinicians, and technology experts to accelerate innovation. Education and workforce development were noted as key components to ensure healthcare systems can effectively adopt and scale these emerging technologies.

Key Takeaways

• Quantum and AI are moving from theory to application in healthcare, with early use cases emerging in drug discovery, biomarker identification, and molecular simulation. 
• Hybrid computing approaches are essential, combining quantum systems, AI, and classical supercomputers to solve biologically complex problems. 
• Cross-sector collaboration is accelerating innovation, with academic medicine and technology leaders working together to build tools, talent pipelines, and infrastructure for next-generation research.

About the IDN Directory

The IDN Directory provides insights into the supply chains for the biggest health systems in the country to give manufacturer reps, distribution reps, and national accounts managers a quick, accurate view of what’s going on with their customers - right now. 

More than just a database, the IDN Directory's supply chain-focused content provides a clear and comprehensive idea of your customers’ supply chain needs and activities, empowering them to achieve success with GPO, Direct, and Regional contracting. 

To schedule a demo of the IDN Directory, email us at Demo@IDNDirectory.com.